Co-Authors
This is a "connection" page, showing publications co-authored by Júlia Vergara-Alert and Joaquim Segalés.
Connection Strength
5.393
-
Pigs are not susceptible to SARS-CoV-2 infection but are a model for viral immunogenicity studies. Transbound Emerg Dis. 2021 Jul; 68(4):1721-1725.
Score: 0.909
-
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain. Proc Natl Acad Sci U S A. 2020 10 06; 117(40):24790-24793.
Score: 0.903
-
Middle East respiratory syndrome coronavirus experimental transmission using a pig model. Transbound Emerg Dis. 2017 Oct; 64(5):1342-1345.
Score: 0.722
-
Searching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirus. One Health. 2017 Jun; 3:34-40.
Score: 0.707
-
Livestock Susceptibility to Infection with Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis. 2017 02; 23(2):232-240.
Score: 0.704
-
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster. Emerg Microbes Infect. 2021 Dec; 10(1):797-809.
Score: 0.245
-
Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein. Emerg Microbes Infect. 2019; 8(1):1593-1603.
Score: 0.201
-
Co-localization of Middle East respiratory syndrome coronavirus (MERS-CoV) and dipeptidyl peptidase-4 in the respiratory tract and lymphoid tissues of pigs and llamas. Transbound Emerg Dis. 2019 Mar; 66(2):831-841.
Score: 0.200
-
Conserved synthetic peptides from the hemagglutinin of influenza viruses induce broad humoral and T-cell responses in a pig model. PLoS One. 2012; 7(7):e40524.
Score: 0.128
-
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report. Open Forum Infect Dis. 2021 Jul; 8(7):ofab329.
Score: 0.060
-
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals. Viruses. 2021 06 12; 13(6).
Score: 0.059
-
Nasal high-flow oxygen therapy in COVID-19 patients does not cause environmental surface contamination. J Hosp Infect. 2021 10; 116:103-105.
Score: 0.059
-
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen. Front Pharmacol. 2021; 12:646676.
Score: 0.059
-
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes. Med (N Y). 2021 Mar 12; 2(3):313-320.e4.
Score: 0.058
-
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity. Sci Rep. 2021 01 28; 11(1):2608.
Score: 0.058
-
Analytical and clinical performance of the panbio COVID-19 antigen-detecting rapid diagnostic test. J Infect. 2021 05; 82(5):186-230.
Score: 0.058
-
Animal models for COVID-19. Nature. 2020 10; 586(7830):509-515.
Score: 0.057
-
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins. Immunotherapy. 2020 12; 12(17):1247-1255.
Score: 0.056
-
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target. F1000Res. 2020; 9:52.
Score: 0.054
-
Experimental infection of dromedaries with Middle East respiratory syndrome-Coronavirus is accompanied by massive ciliary loss and depletion of the cell surface receptor dipeptidyl peptidase 4. Sci Rep. 2018 06 27; 8(1):9778.
Score: 0.048
-
Protective effect of a polyvalent influenza DNA vaccine in pigs. Vet Immunol Immunopathol. 2018 Jan; 195:25-32.
Score: 0.046